Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Politics

Trump signs executive order to make healthcare prices ‘transparent’

by February 26, 2025
February 26, 2025
Trump signs executive order to make healthcare prices ‘transparent’

President Donald Trump on Tuesday signed an executive order directing the departments of the Treasury, Labor, and Health and Human Services to make healthcare prices transparent.

The order directs the departments to ‘rapidly implement and enforce’ the Trump healthcare price transparency regulations, which he claims were slowed by the Biden administration.

The departments will ensure hospitals and insurers disclose actual prices, not estimates, and take action to make prices comparable across hospitals and insurers, including prescription drug prices.

In addition, they will be required to update their enforcement policies to ensure hospitals and insurers are in compliance with requirements to make prices transparent.

‘When healthcare prices are hidden, large corporate entities like hospitals and insurance companies benefit at the expense of American patients,’ the White House wrote in a statement. ‘Price transparency will lower healthcare prices and help patients and employers get the best deal on healthcare.’

The executive order notes a number of concerns with current healthcare pricing, including that prices vary between hospitals in the same region.

‘One patient in Wisconsin saved $1,095 by shopping for two tests between two hospitals located within 30 minutes of one another,’ according to the statement.

The White House claims one economic analysis found Trump’s original price transparency rules, if fully implemented, could deliver savings of $80 billion for consumers, employers and insurers by 2025.

It added that employers will lower their healthcare costs by an average of 27% on 500 common services by better shopping for care.

‘They’ll be able to check them, compare them, go to different locations, so they can shop for the highest-quality care at the lowest cost,’ Trump wrote in the statement. ‘And this is about high-quality care. You’re also looking at that. You’re looking at comparisons between talents, which is very important. And, then, you’re also looking at cost. And, in some cases, you get the best doctor for the lowest cost. That’s a good thing.’

The White House said American patients are ‘fed up with the status quo,’ with 95% saying healthcare price transparency is an important priority. More than 50% said it should be a top priority of the government.

In his first term, Trump took historic action by mandating that hospitals and insurers make prices public.

A lawsuit was filed against the Biden administration in 2023, alleging it did not enforce the prescription drug transparency requirements. 

‘While the prior Administration failed to prioritize further implementation and enforcement of these requirements, President Trump is delivering on his promises to make the healthcare system more affordable and easier to navigate for patients,’ according to the statement.

Fox News Digital previously reported the administration’s tariffs on China will affect drug costs.

Consumers are more dependent on China for medications for anxiety and other psychiatric disorders, such as antidepressants.

This post appeared first on FOX NEWS
previous post
GOPers press for the release of JFK, Epstein files: Here’s why they’re not out
next post
White House confirms who was appointed as acting administrator of DOGE

Related Posts

Judge blocks Trump’s EPA from terminating $14 billion...

March 19, 2025

Dems renew push for limiting presidential clemency powers...

December 4, 2024

Federal agencies scrub climate change from websites amid...

February 3, 2025

Dem voters at Milwaukee rally say they’re fired...

July 24, 2024

US cuts defense ties with Cuba over ‘non-cooperation’...

May 13, 2025

Lone Biden official breaks silence on cognitive decline...

May 29, 2025

Trump’s authority to fire officials questioned in court...

March 7, 2025

Libertarians select Chase Oliver as presidential nominee, very...

May 28, 2024

Morning Glory: Justice Gorsuch takes his case public

August 6, 2024

Hezbollah drone attack in Israel kills multiple IDF...

October 13, 2024

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Latest News

    • Blue state Republicans threaten rebellion if Senate changes key provision in Trump’s ‘big, beautiful bill’

      June 5, 2025
    • Ricketts, Fetterman team up for crackdown on China’s attempts to purchase US farmland

      June 5, 2025
    • Hamas working to ‘sabotage’ Trump-backed aid group with ‘fake news’: Israeli official

      June 5, 2025
    • Longtime Trump loyalist flips on GOP’s ‘big, beautiful bill’

      June 5, 2025
    • Supreme Court rules Wisconsin unconstitutionally discriminated against Christian charity

      June 5, 2025
    • Trump touts ‘very positive’ breakthrough with Xi after slamming China for trade violation

      June 5, 2025

    Categories

    • Business (1,250)
    • Politics (5,854)
    • Stocks (904)
    • World News (457)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved